About antihemop hilic factor
Recombinant factor VIII clotting factor
Used for
- Prevention and treatment of bleeding in haemophilia A.
- Control of bleeding during and after surgery in haemophilia A.
Usual adult dose
Dose is individualized by body weight, bleed severity, target factor level, and response; given intravenously.
Usual dose in children
Used in children; dose is individualized by body weight, bleed severity, target factor level, and response.
Common side effects
- Headache
- Diarrhoea
- Rash
- Development of factor VIII inhibitors, which may reduce treatment effectiveness
Important warnings
- Severe allergic reactions can occur, especially with factor VIII inhibitors.
- Monitor for inhibitors if bleeding is not controlled or factor levels do not rise as expected.
- Not for von Willebrand disease or haemophilia B.
- Use only by intravenous injection.
Pregnancy
Limited human data; use during pregnancy only when clinically needed.
Breastfeeding
Limited information; use when clinically needed after weighing benefits and risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.